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Background. In both Drosophila and the mouse, the zinc finger transcription factor Snail is required for mesoderm formation;
its vertebrate paralog Slug (Snai2) appears to be required for neural crest formation in the chick and the clawed frog Xenopus
laevis. Both Slug and Snail act to induce epithelial to mesenchymal transition (EMT) and to suppress apoptosis. Methodology &
Principle Findings. Morpholino-based loss of function studies indicate that Slug is required for the normal expression of both
mesodermal and neural crest markers in X. laevis. Both phenotypes are rescued by injection of RNA encoding the anti-
apoptotic protein Bcl-xL; Bcl-xL’s effects are dependent upon IkB kinase-mediated activation of the bipartite transcription
factor NF-kB. NF-kB, in turn, directly up-regulates levels of Slug and Snail RNAs. Slug indirectly up-regulates levels of RNAs
encoding the NF-kB subunit proteins RelA, Rel2, and Rel3, and directly down-regulates levels of the pro-apopotic Caspase-9
RNA. Conclusions/Significance. These studies reveal a Slug/Snail–NF-kB regulatory circuit, analogous to that present in the
early Drosophila embryo, active during mesodermal formation in Xenopus. This is a regulatory interaction of significance both
in development and in the course of inflammatory and metastatic disease.
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INTRODUCTION
The process of transforming relatively immotile epithelial cells into
actively migrating mesenchymal cells, known as epithelial to
mesenchymal transition (EMT), is central to a wide range of
biological processes from mesoderm, mesenchyme, and neural
crest formation to pathogenic fibrosis and metastasis [1–4].
Important players in the regulation of EMT are the zinc finger
transcription factors Snail (Snai1) and its vertebrate paralog Slug
(Snai2). In addition to Snail and Slug, a number of other members
of the Snail family have been identified. In Drosophila melanogaster
there are the Snail-like genes Escargot and Worniu [5–7], and the
more divergent Scratch genes [8]. The duplication event that gave
rise to Snail-like and Scratch-like genes appears to have occurred
before the divergence of proteostomes and deuterostomes [9,10].
The involvement of Snail-like proteins in EMT was first
suggested by genetic studies in Drosophila. Mutations in Snail lead to
the disruption of mesoderm and embryonic lethality [11–13]. As in
Drosophila, mice homozygous for a null mutation in the orthologous
Snail gene fail to form normal mesoderm and exhibit early
embryonic lethality [14]. No mesodermal phenotype was observed
in mice homozygous for a null mutation in Slug [15,16]. The
absence of Slug does lead to defects in melanocyte, hematopoietic
stem cell and germ cell development, and epidermal healing [17–
19]. Slug is expressed in the mesoderm in the chick and exposure
of the early embryo to anti-sense oligonucleotides leads to defects
in mesoderm emergence [20]. In X. laevis Slug mRNA is expressed
zygotically in the dorsal mesendoderm; interference with its
function, through the injection of RNAs encoding dominant
negative proteins, leads to defects in the expression of organizer
(Chordin, Cerberus) and ventrally (Xwnt8, Xvent1) expressed genes
[21]. An important concern about such studies involves the
specificity of ‘‘anti-morphic’’ reagents, given the known regulatory
cross-talk between E-box binding Snail, Slug and basic helix-loop-
helix (bHLH) transcription factors (see below).
In both X. laevis and the chick, Slug appears to have an essential
role in neural crest formation [20,22–24]. In contrast, mutation of
Slug has no apparent effect on neural crest formation in the mouse
[15]. This apparent discrepancy was initially ascribed to
a swapping of Slug and Snail expression domains in the mouse
[25,26]. More recent studies, using a combination of constitutive
and conditional knock out mutations, indicate that neither Slug
nor Snail are required for neural crest formation in the mouse, at
least in the cranial region [16].
Snail-like proteins are generally thought to act as transcriptional
repressors, although Sakai et al [27] report that Slug positively
regulates is own expression. Snail, Slug, and Scratch all bind to E-
box sequences (CANNTG) and can antagonize the activity of
bHLH proteins [8,28–31]. In their role as regulators of EMT, Slug
and Snail have been found to suppress expression E-cadherin and
tight junction components and the forced expression of Slug
disrupts adherens junctions, tight junctions, and desmosomes [32–
39]. Slug and Snail also act as inhibitors of apoptosis [40–44]. Slug
has been found to negatively regulate the expression of the pro-
apoptotic p53 [43] and Puma [45] genes. Subsequent studies have
found that Slug is required for the metastasis of human melanoma
cells [46] and has been implicated in lung adenocarcinoma and
breast carcinoma invasiveness [47–49].
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PLoS ONE | www.plosone.org 1 December 2006 | Issue 1 | e106Sequence analysis indicate that Slugs are more conserved than
vertebrate Snails [50]. Lespinet et al [10] grouped chick (Gallus
gallus) and X. laevis Snails with Slugs rather than with other
vertebrate Snails. Slug and Snail have been found to be
functionally similar, but not identical. For example, injection of
RNA encoding Snail rescues the effects of anti-sense Slug RNA
injection in X. laevis [22] and ‘‘Slug and Snail can be can be
functionally equivalent when tested in overexpression studies’’
[23]. Over-expression of Snail leads to expansion of the neural
crest domain in the chick, much as observed following over-
expression of Slug [51,52]. On the other hand, the need for Snail
expression in the early Drosophila embryo cannot be replaced by
either Escargot or Worniu [53]. Snail and Slug differ in their
ability to induce neural crest markers in X. laevis ectodermal
explants [23], even though Slug alone has been found to rescue
the effects on neural crest following the blocking of both Slug
and Snail activity [see 24]. Slug appears to bind less strongly to
regulatory regions in the E-cadherin protein than does Snail
[38], while Slug, but not Snail, has been found to mediate
genotoxin resistance in human mesothelioma cells [54]. A
microarray-based analysis of MDCK epithelial cells found both
common and distinct sets of genes regulated by Slug and Snail
[55]. Given that Snail [56–59] and Slug [60] can be post-
translationally regulated in terms of both stability and in-
tracellular localization, it remains unclear whether the differences
between the two proteins are intrinsic or are due to protein-
specific post-translational effects.
Previous studies of Slug’s role in X. laevis have used either anti-
sense RNA [22] or dominant-negative proteins [21,23,24,61,62]
to disrupt Slug expression and/or activity. As part of a study to
separate the role of Slug in EMT from its role as a regulator of
apoptosis, we designed a modified anti-sense DNA oligonucleotide
(a morpholino) that blocks Slug expression. In the course of
analyzing the ability of the anti-apoptotic protein Bcl-xL to rescue
the phenotypic effects of this morpholino, we uncovered an
essential role for NF-kB as a regulator of Slug expression in the
early embryo, a regulatory interaction analogous to that observed
in the early Drosophila embryo, and not apparently described
previously in a vertebrate.
RESULTS
Previous studies on the role of Slug in Xenopus have relied on
injection of either anti-sense RNA directed against 39 untranslated
region of the SlugA mRNA [22] or RNAs encoding various
dominant-negative proteins [21,23,24,61,62]. To complement
these studies, we developed a morpholino (Slug MO) directed
against the Slug mRNAs. There are two Slug pseudoalleles in X.
laevis, SlugA and SlugB [63]. The Slug MO is a perfect match to the
SlugA mRNA, has three mismatches to the SlugB mRNA and 12
(out of 25) mismatches with the analogous region of the Snail
mRNA (FIG. 1A). The Slug MO blocked the in vitro translation of
SlugA RNA that contained its target sequence but had no effect on
the translation of mycGFP-Slug RNA, which lacks SlugA’s 59
untranslated region (data not shown).
When injected into one cell of two-cell embryos, the Slug
MO (10 ng/embryo) inhibited expression of the mesodermal
markers Xbra (FIG. 1B,C), Xmenf (FIG. 1D,E), and Antipodean
(Apod)(FIG. 1F,G) in late blastula/early gastrula stage embryos.
In neurula stage embryos, the Slug MO inhibited expression of
Sox9 (FIG. 1H), a marker of cranial neural crest and otic
placodes [64,65]. In later stage embryos, the Slug MO led to the
loss of craniofacial cartilages and the otic vesicle (data not
shown), very much as observed in embryos injected with Slug
anti-sense RNA [22]. Injection of a control MO had no apparent
effect on any of the markers examined (Table 1). As a control for
the specificity of the Slug MO, embryos injected with Slug MO
were injected with RNA encoding mycGFP-tagged Slug; both
normal Sox9 expression (FIG. 1I) and craniofacial morphology
(data not shown) were rescued; injection of RNA encoding myc-
GFP did not rescue either phenotype (Table 1 and data not
shown). Previously, we found that injection of Snail RNA rescued
the phenotypic effects of anti-sense Slug RNA injection [22].
This is also the case with the Slug morpholino; injection of
500 pg/embryo Snail RNA rescued expression of both meso-
dermal and neural crest markers in Slug MO injected embryos
(FIG. 1J–L; Table 1).
Maternal Slug RNA can be detected by RT-PCR [22 and data
not shown] and is expressed zygotically in mesoderm [21]. The
loss of Slug function during late bastula/early gastrula stages
would be expected to influence both neural crest and placodal
development, which depend upon signals from the mesoderm [66–
70]. We generated plasmids that encode chimeric proteins
consisting of glucocorticoid-binding regulatory domain [71,72]
and either Slug alone (GR-Slug) or Slug linked to a C-terminal
GFP moiety (GR-Slug-GFP). In the absence of dexamethasone,
both GR-Slug proteins are inactive and had no apparent effect on
the Slug MO’s ability to block Sox9 expression (Table 2). When
Slug MO and GR-Slug RNA injected embryos were exposed to
dexamethasone beginning at stage 11, Sox9 expression was
efficiently recovered (Table 2).
To examine the timing of Slug’s role in neural crest formation,
we compared the effects of activating the GR-Slug-GFP protein in
mid-blastula (stage 8), early gastrula (stage 11), and late gastrula/
early neurula (stage 13) embryos (FIG. 2; Table 2). Activation of
Slug at stage 8 lead to a complete rescue of both mesodermal
(Xbra) and neural crest/placodal (Sox9) marker expression. Efficient
rescue of neural crest/placodal marker expression was also
observed when Slug was activated at stage 11, but rescue was
much less efficient when Slug was activated at stage 13 (FIG. 2;
Table 2).
Bcl-2/Bcl-xL suppression of the Slug MO phenotype
Inhibition of Slug activity by injection of Slug MO (FIG. 3A),
antisense RNA (data not shown) or RNA encoding a dominant
negative version of Slug (ZnfSlug) leads to increased numbers of
apoptotic cells as visualized by TUNEL staining, while injection of
Slug RNA suppresses apoptosis [61]. In our studies, carried out at
stage 16/17, the increase in TUNEL positive cells was most
prominent outside of the neural crest stage Slug expression
domain, and so presumably represent effects on earlier de-
velopmental events.
To distinguish Slug’s pro-EMT and anti-apoptotic activities, we
injected embryos with RNAs encoding the anti-apoptotic proteins
Bcl-2 (human) and Bcl-xL (X. laevis); both had similar effects and
observations using Bcl-xL are show here. As expected, injection of
Bcl-xL RNA blocked the Slug MO induced increase in TUNEL
staining (FIG. 3B). Bcl-xL also rescued the expression of the early
mesodermal markers Apod (FIG. 3C,D) and Xbra (FIG. 3E,F), the
neural crest/otic placode marker Sox9 (FIG. 3G,H; Table 1), and
craniofacial morphology (data not shown). In stage 16/17
embryos, injection of Bcl-xL RNA led to a dramatic increase in
the level and spatial extent of Slug expression (FIG. 3I). In
ectodermal explants (animal caps), prepared at stage 8/9 from
embryos injected with Bcl-xL RNA, and analyzed at stage 11
(,3 hours later), there was a small (,26) but reproducible
increase in the level of Slug mRNA, as determined by quantitative
RT-PCR (FIG. 3J).
A Vertebrate NF-kB-Slug Loop
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Bcl-2 and Bcl-xL are structurally similar cytoplasmic proteins. Bcl-
2 can influence gene expression through effects on IkB kinase
activity (IkK)[73–77]. To examine Bcl-xL’s effects on NF-kB
activity in Xenopus, we used the NF-kB responsive p3XkB-Luc
reporter plasmid together a mutated form of human IkBa (IkBsa)
and acetyl-11-keto-b-boswellic acid (AKBA). In IkBsa serines 32
and 36, normally phosphorylated by IkK, are mutated to alanines.
The stable IkBsa polypeptide acts as a dominant repressor of NF-
kB activity [78]. AKBA inhibits IkK activation [79–81]. Treating
animal caps with 50 mM AKBA stabilized an epitope-tagged form
of Xenopus IkBa (FIG. 4A). Fertilized eggs were injected with
p3XkB-Luc plasmid DNA, pTK-Renilla luciferase plasmid DNA
(as a normalization control), and Bcl-xL RNA alone or together
with IkBsa RNA; animal caps were prepared and analyzed for
luciferase activity at stage 11. Alternatively, fertilized eggs were
injected with p3XkB-Luc and pTK-Renilla DNAs and Bcl-xL
RNA, animal caps were prepared and then incubated in control
media or in media containing AKBA. Bcl-xL increased NF-kB
reporter activity and this increase was blocked by both IkBsa and
AKBA (FIG. 4B). On its own, AKBA had little effect on reporter
activity.
Bcl-xL and Slug regulation of Rel expression
Five NF-kB subunit genes have been characterized in X. laevis:
RelA/Rel1 [82,83], Rel2 [84], Rel3 [85], RelB [86] and Xp100
[87]. All five RNAs are supplied maternally and their levels drop
at the onset of zygotic transcription (stage 8/9)(FIG. 5A). As
development proceeds Rel2, Rel3 and Xp100 RNAs are again
detectable by RT-PCR (28 cycles), while RelB RNA does not
reappear until after stage 35 [86]. Bcl-xL RNA levels appear
constant throughout this period [88](FIG. 5A). In stage 16/17
embryos, RelA, Rel2, Rel3, and Xp100 RNAs can be readily
detected by RT-PCR in the anterior-dorsal quadrant of the
embryo; the same region where Slug and Sox9 are normally
expressed (FIG. 5B). RelA appears concentrated in the anterior
dorsal sector, while Rel2 and Rel3, and to a lesser extend Xp100
appear to be present at similar levels throughout the embryo.
To explore the mechanism of Bcl-xL regulation of Slug and NF-
kB, we generated a plasmid encoding a glucocorticoid-binding
Figure 1. Slug morpholino effects: Panel A is a comparison of the Slug morpholino sequence (‘‘MO’’) with X. laevis SlugA, SlugB, and Snail RNA
sequences; start codons are underlined. B–G: Injection of the Slug MO (10 ng/embryo) blocks the expression of Xbra (B-uninjected, C-Slug MO
injected), Xmenf (D-uninjected, E-injected), and Antipodean (Apod)(F-uninjected, G-injected). Arrows (C,E,G) point to region of suppression; vegetal
pole (‘‘VP’’) is indicated. In G, the red staining is due to a b-galactosidase lineage marker. H: Injection of the Slug MO into one cell of a two cell embryo
blocks the expression of Sox9 on the injected side (arrow); ‘‘*’’ marks otic placode domain of Sox9 expression. I: Sox9 expression in Slug MO injected
embryos is rescued by co-injection of mycGFP-Slug RNA (650 pg/embryo). In analogous studies, the effects of the Slug MO (10 ng/embryo) on Xbra
(J), Apod (K) and Sox9 (L) expression were rescued by injection of Snail RNA (500 pg/embryo). In H, I and L, the line marks midline of the embryo, with
anterior (‘‘An’’) and posterior (‘‘Ps’’) indicated.
doi:10.1371/journal.pone.0000106.g001
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dexamethasone, GR-BclxL-GFP does not alter Slug, RelA, Rel2
or Rel3 RNA levels, while addition of dexamethasone leads to
their increase (FIG. 5C,D), similar to that seen using the non-
hormone regulated form of Bcl-xL (FIG. 3J). No effect was
observed on Xp100 RNA levels (data not shown). While these
effects are small, i.e., 2–3 fold, they are highly reproducible.
Adding the protein synthesis inhibitor emetine blocks the
dexamethasone-dependent increase in Slug and Rel2 RNA levels,
but not the increase in RelA or Rel3 RNA levels; emetine alone
had no reproducible effect on RNA levels (FIG. 5C,D). These
results suggest that Bcl-xL acts directly to regulate RelA and Rel3,
and indirectly to regulate Slug and Rel2 RNA levels. By ‘‘direct’’
we mean a regulatory interaction that does not require on-going
protein synthesis (see Discussion). Bcl-xL activation also leads to an
increase in the level of Snail RNA (FIG. 5E); this increase does not
appear to involve effects on Slug RNA, since it occurs in the
presence of the Slug morpholino.
AKBA treatment blocked Bcl-xL’s ability to increase levels of
Slug, Snail and RelA RNAs (FIG. 5F), suggesting that Bcl-xL acts
on these RNAs, as it does on the NF-kB responsive reporter, by
increasing IkB kinase activity. RelADSP is a dominant negative
form of RelA [89]; it dimerizes with other NF-kB subunit proteins
and blocks their activity. When co-injected with RNAs encoding
Rel3 or Xp52, the active form of the NF-kB subunit protein
Xp100 [87], RelADSP inhibited their ability to activate of the
3XkB-Luc reporter (FIG. 5G) and inhibited Bcl-xL’s ability to
increase RelA and Slug RNA levels (FIG. 5H), indicating that
active NF-kB is required for Bcl-xL to induce increases in Slug and
RelA RNA levels.
Assuming that Bcl-xL acts to rescue the effects of the Slug MO
through its ability to regulate NF-kB activity, injection of RelA
RNA should be able to rescue the Slug MO phenotype. In
embryos injected unilaterally with the Slug MO, injection of RelA
RNA lead to re-appearance of both Xbra (FIG. 6A,B) and Apod
(FIG. 6C,D) RNAs. In later stage, Slug MO-injected embryos,
injection of RelA RNA lead to the reappearance of Sox9
expression in both the neural crest and otic placode regions,
(FIG. 6E,F). A similar rescue of Sox9 expression in Slug MO
injected embryos was observed upon injection of Rel3, or Xp52
RNAs (600 pg/embryo)(Table 1). We have not examined RelA’s
effects on Slug RNA in Slug MO injected embryos because
morpholinos typically stabilize, rather than induce the degradation
of, their target RNAs (unpubl. obs.); RelA does induce an increase
in Slug RNA levels, as monitored by in situ hybridization, when
injected on its own (data not shown – see below).
To complement these studies, we examined the effects of treating
embryos with AKBA or injecting one cell of two cell embryos with
either IkBsa or RelADSP RNAs. AKBA treatment, beginning at the
4-cell stage, led to a noticeable decrease in the intensity of Xbra
RNA staining in early gastrula stage embryos (FIG. 6G), but had
little reproducible effect on Sox9 RNA levels in neurula stage
embryos (data not shown). Injection of IkBsa RNA lead to the
suppression of Xbra (FIG. 6H; Table 1) and the reduction of Sox9
(FIG. 6I) expression. Injection of RelADSP RNA inhibited
expression of Xbra (FIG. 6J), Apod (FIG. 6K), and Sox9 (FIG. 6L).
NF-kB regulation of Slug
To examine whether of NF-kB directly regulates Slug and Snail
RNA levels, we first characterized the effects of RelA and
RelADSP in animal caps; injection of RelA RNA lead to an
increase, while RelADSP RNA lead to a decrease in Slug RNA
levels (FIG. 7A). Using a dexamethasone-regulated form of RelA,
GR-RelA, we found a similar effect – in the presence of
Table 1. Slug Morpholino and Rescue experiments
......................................................................
Injection N Unaffected Reduced/absent In situ
Slug MO
@ 42 2/42 (5%) 40/42 (95%) Sox9
(stage 16)
39 11/39 (28%) 28/39 (72%)
20 6/20 (30%) 14/20 (70%)
37 4/37 (10%) 33/37 (92%)
47 4/47 (8%) 43/47 (90%)
Control MO 40 40/40 (100%) 0/40 (0%) Sox9
32 32 (100%) 0/32 (0%)
26 26/26 (100%) 0/26 (0%)
Slug MO+mycGFP-Slug
RNA
45 39/45 (87%) 6/45 (13%) Sox9
42 37/42 (83%) 5/42 (17%)
23 20/23 (87%) 3/23 (13%)
43 28/43 (65%) 15/43 (35%)
Slug MO 30 5/30 (16%) 25/30 (84%) Xbra
27 2/27(7%) 25/27(93%) Xmenf
22 4/22(18%) 18/22(82%) Apod
26 3/26 (12%) 23/26(88%) Sox9
Slug MO+Snail RNA 56 53/56(95%) 3/56(5%) Xbra
28 25/28(89%) 3/28(11%) Xmenf
24 25/28(89%) 3/28(11%) Apod
46 42/46 (91%) 4/46(9%) Sox9
Slug MO+mtGFP RNA 28 5/28 (18%) 23/28 (82%) Sox9
Slug MO+hBcl2 RNA 24 22/24 (92%) 2/24 (8%) Sox9
15 14/15 (93%) 1/15 (7%)
41 27/41 (66%) 14/41 (34%)
49 32/49 (65%) 17/49 (35%)
Slug MO+Bcl-xL RNA 32 26/82 (81%) 6/32 (19%) Sox9
22 16/22 (72%) 2/22 (28%)
Slug MO 51 8/51 (15%) 43/51 (84%) Sox9
33 6/33 (18%) 27/33(82%)
SlugMO+RelA 40 23/40 (58%) 17/40 (42%) Sox9
SlugMO+Re3 86 65/86 (75%) 21/86 (25%) Sox9
SlugMO+Xp52 72 46/72 (64%) 26/72 (36%) Sox9
RelADSP 11 3/11 (27%) 8/11 (72%) Slug
26 8/26 (31%) 18/26(69%)
Slug MO 46 4/46 (9%) 42/46 (91%) Xbra
(stage 11)
Slug MO+Bcl-xL 35 26/35 (74%) 9/35(26%) Xbra
Slug MO+RelA 40 29/40 (73%) 11/40 (27%) Xbra
RelADSP 28 6/28 (22%) 22/28 (78%) Xbra
IkBsa (500 pg/embryo) 32 9/32 (28%) 23/32 (72%) Xbra
(stage 11)
16 5/16 (31%) 11/16 (69%) Slug
(stage 16)
27 11/27 (41%) 16/27 (59%) Sox9
(stage 16)
@The SlugMO was injected at 10 ng/embryo into one cell of a two-cell embryo;
mycGFP-Slug RNA was injected at 500 to 650 pg/embryo; Snail RNA was
injected at 500 pg/embryo, Bcl-2, Bcl-xL, and RelA RNAs were injected at
600 pg/embryo, the RelADSP was injected at 650 pg/embryo.
doi:10.1371/journal.pone.0000106.t001
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PLoS ONE | www.plosone.org 4 December 2006 | Issue 1 | e106dexamethasone GR-RelA produced an emetine-insensitive in-
crease in Bcl-xL (FIG. 7B), Slug, and Snail RNAs (FIG. 7C). Given
RelA’s ability to induce Sox9 expression in Slug MO injected
embryos (see above), we examined RelA’s effect on Sox9 RNA
levels; activation of RelA led to an increase Sox9 RNA levels even
in the presence of emetine (FIG. 7C).
Targets of Slug regulation
In Drosophila Dorsal, which encodes a RelA homolog, regulates Snail
expression, and Snail in turn regulates Dorsal expression [see 90,
91]. In animal caps, the Slug MO decreased and mycGFP-Slug
increased RelA RNA levels (FIG. 8A), suggesting an analogous
Table 2. Timing of Slug Rescue
..................................................................................................................................................
Injection * Probe Number of embryos Percentage unaffected Percentage reduced
Slug MO+GR-Slug
2Dexamethasone Sox9 27 6/27 (22%) 21/27 (78%)
+Dexamethasone at stage 11 Sox9 43 35/43 (81%) 8/43 (19%)
Slug MO+GR-Slug-GFP
2Dexamethasone Sox9 35 9/35 (25%) 26/35 (75%)
+Dexamethasone at stage 11 Sox9 85 77/85 (91%) 8/85 (9%)
Activation time-course
Slug MO+GR-Slug-GFP
2Dexamethasone Sox9 32 6/32 (18%) 26/32 (82%)
+Dexamethasone at stage 8 Sox9 36 30/36 (83%) 6/36 (17%)
+Dexamethasone at stage 11 Sox9 29 20/29 (68%) 9/29 (32%)
+Dexamethasone at stage 13 Sox9 31 8/31 (26%) 23/31 (74%)
2Dexamethasone Xbra 25 0/25 (0%) 25/25 (100%
+Dexamethasone at stage 8 Xbra 33 33/33 (100%) 0/33 (0%)
*One cell of a two-cell embryo was injected with SlugMO (10 ng/embryo) and GR-Slug-GFP (650 pg RNA/embryo). Ethanol-dissolved dexamethasone (20 mM) was
added to the culture medium at stages 8,11,13; and maintained until the embryos were fixed at stage 10 for in situ hybridization analysis for XBra or at stage 16/17 for
Sox9.
doi:10.1371/journal.pone.0000106.t002
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Figure 2. Timing of Slug rescue of Slug MO phenotypes: To analyze the timing of Slug activity in the early embryo, we injected one cell of two cell
embryos with Slug MO (10 ng/embryo) together with RNA (650 pg/embryo) encoding the chimeric GR-Slug-GFP protein. A: In the absence of the
activating drug dexamethasone, the Slug MO phenotype, i.e. suppression of Xbra expression in stage 11 embryos (A)(arrow) and suppression of Sox9
expression in stage 16 embryos (D), was unaltered. When embryos were treated with dexamethasone (20 mM) beginning at stage 8, there as an
essentially complete rescue of Xbra (B,C) and Sox9 expression (E,H). Treatment of embryos with dexamethasone at stage 11 (early gastrulation) was
also effective at rescuing Sox9 expression (F,H), while addition of dexamethasone at stage 13 (late gastrulation/early neurulation) produced at most
a partial and inefficient rescue of Sox9 expression (G,H).
doi:10.1371/journal.pone.0000106.g002
A Vertebrate NF-kB-Slug Loop
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regulatory targets, we used the GR-Slug construct; its activity in
the presence of dexamethasone is similar to that of mycGFP-
tagged and untagged versions of Slug. In animal caps, both
mycGFP-Slug and dexamethasone-activated GR-Slug lead to
increased levels of the neural crest marker Zic5 [92,93](data not
shown) and Sox9 (FIG. 8B). In contrast Aybar et al., [23] reported
that Slug did not induce neural crest markers in animal caps
analyzed at stage 20, ,22 hours after fertilization. To reconcile
these observations, we analyzed animal caps derived from embryos
injected with Slug RNA at stage 11 (our standard analysis time
point) and stage 16; Sox9 RNA levels were increased at stage 11
but had returned to control levels by stage 16 (FIG. 8C), indicating
that factors in addition to Slug are required to maintain Sox9
expression. In independent studies we have found that levels of
Sox3 and SoxD RNAs, whose expression is associated with early
germ layer and neural differentiation, change dramatically in the
period between stage 11 and 14 (C. Zhang, T. Grammer & M.W.
Klymkowsky, unpubl. obs). GR-Slug positively but indirectly
increased levels of Bcl-xL (FIG. 8D), Sox9 (FIG. 8E), RelA, Rel2,
and Rel3 RNAs (FIG. 8F), but had no effect on Xp100 RNA levels
(data not shown).
Figure 3. Rescue of Slug MO effects by Bcl-xL A: Injection of the Slug MO leads to an increase in TUNEL staining. B: This increase is blocked by the
injection of Bcl-xL RNA (600 pg/embryo and co-injected with LacZ RNA). Injected sides of embryos are marked by an ‘‘*’’ and red staining; line marks
midline of the embryo, with anterior (‘‘An’’) and posterior (‘‘Ps’’) indicated. Injection of Bcl-xL RNA (600 pg/embryo) rescues Apod (C- Slug MO
injected, D-Slug MO+Bcl-xl RNA injected), Xbra (E- Slug MO injected, F-Slug MO+Bcl-xl RNA injected), and Sox9 expression (G- Slug MO injected, H-
Slug MO+Bcl-xL RNA injected). I: Injection of Bcl-xL RNA into one cell of a two-cell embryo led to a dramatic increase in the intensity and extent of
Slug expression at stage 16; the region of Slug expression on the uninjected (control) side of the embryo is indicated by the dashed circle. J: Injection
of Bcl-xL RNA produced an increase in Slug RNA levels in animal caps prepared at stage 8/9 and analyzed by QRT-PCR when uninjected embryos
reached stage 11. Ornithine decarboxylase (ODC) was used as normalization control. RNA levels in the control case were set to 100%.
doi:10.1371/journal.pone.0000106.g003
Figure 4. Characterization of Bcl-xL effects on NF-kB activity. A: Fertilized eggs were injected with RNA (650 pg/embryo) encoding Xenopus IkBa-
V5. Beginning at stage 8, experimental embryos were treated with 50 mM AKBA and analyzed at stage 11 by SDS-PAGE/immunoblot using an anti-V5
antibody and the antiSOX3c antibody to visualize endogenous Sox3 protein as a loading control. AKBA treatment stabilized the IkBa-V5 polypeptide.
B: Fertilized eggs were injected with p3XkB-firefly luciferase (‘‘3kB-Luc’’) and pTK-Renilla luciferase (‘‘RL-TK’’) DNAs (10 pg/embryo each) either alone
(‘‘Con’’) or together with Bcl-xL (500 pg/embryo) RNA, or Bcl-xL and IkBsa (600 pg/embryo) RNAs. Alternatively, animal caps prepared from Bcl-xL
RNA injected embryos were cultured in either control buffer (0.1% DMSO), 20 mMo r5 0mM AKBA. At stage 11, caps were analyzed for luciferase
activity. Bcl-xL induced an increase in 3XkB-Luc activity that was blocked by either IkBsa or AKBA. Error bars in B reflect standard deviation from the
mean of multiple experiments.
doi:10.1371/journal.pone.0000106.g004
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early embryonic apoptotic program in X. laevis, while the effector
caspases-3 and -6 act downstream [94]. Caspase-9 appears to be
a direct and negatively regulated target of Slug, while caspases-3
and -6 appear to be indirect targets (FIG. 8G). In embryos, Slug
MO induced an increase in caspase activity as indicated by
staining with the anti-activated caspase antibody CM1 and
increased cleavage of a caspase-3 target peptide (data not shown).
These results extend those of Tribulo et al., [61] and establish,
apparently for the first time, a direct regulatory interaction
between Slug and caspase-9.
DISCUSSION
In analogy with polymerization reactions, scientific studies often
involve distinct initiation and catalytic events. In this work, the
Figure 5. Bcl-xL regulation of NF-kB RNAs: A: RNA was extracted from eggs and embryos at various stages and analyzed by RT-PCR (28 cycles); levels
of RelA, Rel2, Rel3, RelB and Xp100 RNAs drop between stage 7 and 9 and, except for RelB, increase following gastrulation (stage 12/13). Levels of Bcl-
xL RNA appear relatively constant throughout this period of development. B: At stage 16, embryos were dissected into anterior dorsal (AD), posterior
dorsal (PD), anterior ventral (AV), and posterior ventral (PV) quadrants and RNA was analyzed by RT-PCR; RelB was not expressed at this stage;
expression of RelA, Slug and Sox9 are restricted to the anterior dorsal quadrant, while Bcl-xL, Rel2, Rel3, and Xp100 RNAs can be detected throughout
the embryo. C, D: Animal caps were prepared from embryos injected with GR-Bcl-xL-GFP RNA (‘‘GRBclxL’’)(600 pg/embryo) and either left untreated
(0.1%DMSO)(‘‘Con’’), treated with 20 mM dexamethasone (‘‘+Dex’’), treated first with 100 mg/ml emetine and then dexamethasone (‘‘+Dex+Eme’’), or
treated with emetine alone (‘‘+Eme’’), and analyzed at stage 11 for Slug, RelA (C), Rel2 and Rel3 (D) RNA levels. Treatment with emetine blocked the
increase in Slug and Rel2, but not RelA and Rel3 RNAs; emetine treatment alone produced control or slightly reduced levels of Slug and Rel RNAs. E:
Activation of the GR-Bcl-xL-GFP protein in embryos injected with the Slug MO produces an increase in the level of Snail RNA, analyzed at stage 11. F:
In animal caps derived from GR-BclxL-GFP RNA injected embryos, AKBA (50 mM) inhibited the dexamethasone-induced increases in Slug, Snail, and
RelA RNA levels; while treatment with AKBA alone lead to a decrease in Slug, Snail and RelA RNA levels. G: In animal caps, injection of RelADSP RNA
(600 pg/embryo) blocked Rel3 and Xp52 RNA induced activation of the 3XkB reporter. H: The ability of Bcl-xL RNA to increase levels of RelA and Slug
RNAs in animal caps was blocked by the co-injection of RelADSP RNA. Error bars in C–H reflect standard deviation from the mean of multiple
experiments.
doi:10.1371/journal.pone.0000106.g005
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PLoS ONE | www.plosone.org 7 December 2006 | Issue 1 | e106Figure 6. NF-kB regulation of mesodermal and neural markers: The Slug MO induced loss of Xbra (A,B), Apod (C,D) and Sox9 (E,F) expression was
rescued by injection of RelA RNA (600 pg/embryo)(A, C, E-Slug MO alone, B, D, F-Slug MO+RelA RNA). G: Treatment of early embryos with AKBA
(50 mM from the 4-cell stage on) lead to a decrease in Xbra staining (control and AKBA-treated embryos marked). Injection of RNA encoding IkBsa
(H,I) or RelADSP (J–L) had effects similar to that seen in Slug MO injected embryos; that is, both induced the reduction of Xbra (H,J), Apod (K) and
Sox9 (I,L) RNA staining. AKBA treatment had no reproducible effect on Sox9 expression (data not shown). Arrows mark affected regions.
doi:10.1371/journal.pone.0000106.g006
Figure 7. NF-kB’s regulatory targets: A: In animal caps, RelA lead to an increase in Slug RNA levels, while RelADSP produced a decrease. When
activated by dexamethasone (+Dex), the hormone-regulated form of RelA, GR-RelA (600 pg RNA/embryo), induced a similar increase in the levels of
Slug RNA, as well as Snail, Sox9 (B), and Bcl-xL (C) RNAs compared to animal caps from GR-RelA injected embryos not exposed to dexamethasone.
Similar effects were seen in the presence of emetine (+Dex+Eme,), while emetine alone (+Eme) had little effect on any of measured RNA levels. Error
bars in reflect standard deviation from the mean of multiple experiments.
doi:10.1371/journal.pone.0000106.g007
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PLoS ONE | www.plosone.org 9 December 2006 | Issue 1 | e106initiator was the observation that anti-apoptotic proteins rescue
the effects of blocking Slug expression on mesodermal and neural
crest markers. Bcl-xL produced an increase in both Slug and Snail
RNAs and Snail itself is sufficient to suppress the Slug morpholino
phenotype (FIG. 1J–L)[22]. The role of catalyst was played by the
observations of Kirshenbaum and colleagues [73–75,95], who
found that Bcl-2 regulates NF-kB activity by activating IkB kinase
(IkK). Activation of IkK induces the degradation of inhibitory IkB
proteins, leading to increased NF-kB activity. Our studies using
the dominant negative IkBsa protein, the IkK inhibitor AKBA,
and the dominant negative form of RelA, RelADSP, indicate that
Bcl-xL regulates Slug RNA expression via NF-kB in the early X.
laevis embryo (FIG. 9).
Mapping regulatory interactions
In mammalian epithelial cells over-expression of Bcl-2 has been
found to promote EMT [96] and suppress cadherin expression
[97]. Neither study, however, examined the effects of Bcl-2
expression on the levels of Slug or Snail RNAs. NF-kB itself has
been implicated in EMT [98], and has been found to regulate Snail
stability and activity through effects on glycogen synthase kinase 3
[99]. In X. laevis, few promoters have been rigorously defined. It is
possible, however, to tentatively classify regulatory interactions as
direct or indirect based on the ability of hormone-regulated
proteins to influence target RNAs in the presence of protein
synthesis inhibitors. If a regulatory interaction requires or depends
upon on-going protein synthesis, it is classified as ‘‘indirect’’;
‘‘direct’’ interaction are not blocked by protein synthesis inhibitors.
Regulatory interactions are often complex and multifaceted; it is
important to remember that conclusions based on hormone-
regulated proteins need to be characterized further. For example,
if a transcription factor regulates the expression of a gene encoding
a microRNA, which in turn regulates the stability of a target RNA,
its effects will appear as direct even though they are mechanis-
tically indirect. As another example, NF-kB acts as both
a transcriptional regulator [100] and has been reported to
destabilize certain RNAs [101]. This latter activity would appear
as direct in our system. In this light it is interesting to note that
activation of GR-RelA leads to a protein-synthesis independent
decrease in levels of p53 RNA (unpubl. obs); whether this reflects
transcriptional, post-transcriptional, or microRNA-mediated reg-
ulation is not yet resolved.
Neither Bcl-2 or Bcl-xL are thought to regulate gene expression
through direct interactions with DNA or transcription factors, but
rather through effects on various kinases [see 74–76]. Using
a hormone-regulated form of Bcl-xL, RelA and Rel3 appear to be
direct, while Rel2 and Slug appear to be indirect targets of Bcl-xL
regulation. The ability of Bcl-xL to induce changes in RelA, Slug
and Snail RNA levels is inhibited by both the dominant negative
form of RelA, RelADSP and the IkK inhibitor AKBA, suggesting
that Bcl-xL activates IkK, which initiates the destruction of IkB
polypeptides, leading to the activation of pre-existing NF-kB,
which in turn regulates target genes (FIG. 9). The presence of
RelADSP or AKBA blocks these NF-kB-dependent processes and so
blocks the effects of Bcl-xL on both ‘‘direct’’ and ‘‘indirect’’ targets.
NF-kB regulation of Slug
NF-kB subunit proteins are expressed ubiquitously and play a key
role in cellular inflammation and tumor progression [102–106].
NF-kB is known to have a number of regulatory targets, including
IkBa [107,108], which acts to repress, and so limit, NF-kB
activity. In mammalian systems, NF-kB regulates the expression of
a range of anti-apoptotic proteins, including the anti-apoptotic
caspase inhibitor proteins (IAPs), Bcl-2, and Bcl-xL [109–113] and
decreases the activity of the pro-apoptotic p53 protein in renal cell
carcinoma cells [114]. In addition, NF-kB and p53 can inhibit
each other’s activities by competing for the limited pool of CBP/
p300 within the cell [115]. In X. laevis RelA/NF-kB is a positive
regulator of Bcl-xL, Slug and Snail. Slug’s ability to down-regulate
the pro-apoptotic genes Caspase-9 [61] and Puma [45] would be
expected to generate an over-all anti-apoptotic state.
In this light, the decrease in NF-kB RNA levels at the
midblastula transition (FIG. 5A) may be permissive in the
regulation apoptotic processes in later stage embryos [116–118].
A number of drugs, e.g. AKBA and curcumin [79,81,119–121],
inhibit NF-kB activity and increase apoptosis, perhaps by reducing
levels of Slug and/or Snail expression, which may explain at least
part of their anti-tumor effects.
Slug regulation of NF-kB
In X. laevis Slug activates an NF-kB responsive reporter and acts
indirectly to increase levels of RelA, Rel2, and Rel3 RNAs. In
Drosophila Snail also acts indirectly to regulate Dorsal (RelA) by
inhibiting expression of WntD, which acts to inhibit activation of
Dorsal [90,91]. How Slug regulates RelA/Rel3 expression in
Xenopus remains unclear, but preliminary studies indicate that
Drosophila WntD, as well as a number of Xenopus Wnts, inhibit
Bcl-xL-mediated activation of the 3XkB-Luc reporter and reduce
RelA RNA levels (Zhang & Klymkowsky, unpubl. obs.). Whether
Slug acts through the regulation of a Wnt or some other
intermediate, it is apparent that Slug can increase NF-kB activity
and RNA levels in the early Xenopus embryo. Our studies
indicate that NF-kB regulates both Slug and Snail RNA levels and
plays an essential role in mesoderm formation. The presence of
a heretofore unrecognized NF-kB–Slug/Snail regulatory loop in
a vertebrates should have important consequences for our
understanding the conserved and divergent evolutionary mechan-
isms involved in germ layer specification, as well as practical
implications for therapeutic interventions that target NF-kB and
Slug/Snail-mediated EMT and anti-apoptotic processes.
MATERIALS AND METHODS
Embryos and animal caps
X. laevis embryos were obtained following standard protocols
[22,72] from adult animals purchased from Xenopus I, Inc.
(Dexter, MI). Embryos were staged according to Nieuwkoop and
Faber [122]. Fertilized eggs or one-cell of two-cell embryos were
injected with 10–20 nL of solution; ectodermal explants (animal
caps) were prepared from stage 8/9 embryos using a Gastro-
Figure 9. Bcl-xL-Slug-NF-kB network: This diagram focuses on the
regulatory interactions uncovered in the course of our studies (see text
for caveats associated with the identification of direct interactions).
Protein names are underlined, gene names are in italics. Bcl-xL appears
to activate NF-kB through effects on IkK activity and IkB stability. NF-kB
acts directly to regulate Slug, Snail, RelA, and Rel3 levels; NF-kB
regulation of the expression of its inhibitor IkB is based on data from
mammalian systems. Caspase-9 was the only direct target of Slug
identified in our studies; indirect interactions are indicated by dotted
lines.
doi:10.1371/journal.pone.0000106.g009
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TM (Xenotech) and cultured until control embryos reached
either stage 11 or stage 16/17 [72,123]. In experiments involving
hormone activation of chimeric polypeptides, whole embryos or
animal caps were treated with 20 mM dexamethasone (Sigma)
alone, or were pretreated for 30 minutes with 100 mg/mL of the
protein synthesis inhibitor emetine (Sigma)[124], prior to dexa-
methasone and emetine treatment. In contrast to cycloheximide
[125], emetine does not induce nodal gene expression under these
conditions [126,127]. RNA was isolated and subjected to either
standard or quantitative RT-PCR (QRT-PCR) analysis as
described previously [123]. Primers for PCR analyses were:
caspase-3 [F59AAGTCTGGAACATCGCAGG39;R 5 9TAAAT-
GAGCCCCTCATCACC39];
caspase-6 [F59TGGACATCAAGGACTGTGGA39;R 5 9CTG-
AACATCAAACCCCAGGT 39];
caspase-9 [F59CCGATGGAGTTTCAAGCAAA39;R 5 9GAC-
TGGGCAGAAGGATTCAG39];
Bcl-xL/Xr11 [F59GTCGGCCTGTATGGAAAGAA39;R 5 9C-
ATGATAGGCGACCCAGTG39] [61];
Slug [F59CAATGCAAGAACTGTTCC39;R 5 9TCTAGGC-
AAGAATTGCTC39];
Snail [F59AAGCACAATGGACTCCTT39;R 5 9CCAATAGT-
GATACACACC39][22];
Sox9 [F59GAGAATGGTAGGCAGCCACCTCGC39;
R59CTGTTGCTGTTGGTCACTGTAATG39](this study);
RelA [F59GCGGATCCGAAGGGCGCTCTGCTGGAAGC39;
R59GCGAATTCAATTTCATCTCCTCCCAAGCA39][86];
Rel2 [F59GCAGTTCCATCACAGCTAAAC39;R 5 9GGTG-
TCTGGTAGCCTTTGGTC39];
Rel3 [F59ATCATGGAAAGTTTGAGGGCA39;R 5 9GGGTG-
GTAACTAAATGGTGTA39];
RelB [F59CCTCAGTACTGTAACTGTCGC39;R 5 9GCAG-
TCTTTACCTACAAGGCC39];
Xp100 [F59CTGATAAACATGCCAGATTAC39;R 5 9GCAC-
ATCAGAGTCACTCTCAG39](this study.
Plasmids, morpholinos, and reporters
pCS2mycGFP-Slug and pCS2mt-GFP have been described pre-
viously [22]. Plasmids encoding dexamethasone-regulated versions
of Slug, RelA and Bcl-xL were generated by subcloning into the
pCS2GR-Sox7-GFP plasmid [127]. A plasmid encoding an
epitope-tagged form of Xenopus Bcl-xL (Xr11)[88] was supplied
by James Maller (UCHSC, Denver, CO); the pCS2-LacZ plasmid
was supplied by Jing Yang (Columbus Children’s Research
Institute); a plasmid encoding human Bcl-2 was supplied by Jean
Gautier (Columbia University); plasmids encoding Xenopus
RelA(Rel1), myc-tagged Rel3, Xp52 (the active form of Xp100),
and a dominant-negative form of RelA, RelADSP, were supplied
by Hugh Woodland (U. Warwick)[83]Beck et al 1998), Ken Kao
(U. Newfoundland)[85,128,129], and Jun-ichiro Inoue (U. To-
kyo)[86,87]. The Xp52 sequence was subcloned into pCS2 to form
pCS2-Xp52. The p3XkB-Luc plasmid, which contains three kB
binding sites driving expression of firefly luciferase [130] and
a plasmid encoding a form of human IkBa (IkBsa) in which serines
32 and 36 have been mutated to alanines [78] were supplied by
Lorrie Kirshenbaum (U. Manitoba). IkBsa is resistant to IkB
kinase phosphorylation and subsequent proteolytic degradation,
and so acts as a dominant-negative regulator of NF-kB activity
[75,78]. The coding sequence for X. laevis IkBa (GENBANK
Accession AAH77876) was isolated by RT-PCR and subcloned
into a pCS2-V5 plasmid to form pCS2-XIkBa-V5. Acetyl-11-
keto-b-boswellic acid (AKBA), a pentacyclic triterpene, inhibits
IkBa phosphorylation and degradation in mammalian systems
[79–81]; it has also been reported to inhibit topoisomerases
[131,132] and 5-lipoxygenase [133]. The effects of AKBA on
IkBa-V5 stability in Xenopus were analyzed using SDS-PAGE/
immunoblot with an monoclonal anti-V5 epitope antibody
(Invitrogen) and the antiSOX3c antibody [123]. Reporter assays
were carried out using the dual luciferase system [123]. Capped
RNAs were generated using Ambion mMessage mMachine kits.
Both fluorescein-conjugated and unconjugated forms of a morpho-
lino directed against the 59 UTR and coding sequence of the SlugA
and SlugB genes (FIG. 1A) [59CGTGGCATTTTCACTGCG-
GGCGGGA39] were used with identical results; these and
a control morpholino were purchased from Gene Tools, Inc.
TUNEL, anti-caspase staining and caspase cleavage
assays
Fixed and sectioned embryos [134] were stained by TdT-mediated
dUTP-biotin nick end-labeling (TUNEL) using a peroxidase-based
kit purchased from Molecular Probes, following the manufacturer’s
instructions. Whole-mount TUNEL [135] was carried out using the
protocol on the Harland Lab website
1. The rabbit anti-activated
caspase 3 antibody CM1 (BD Bioscience Pharmingen) was used in
whole-mount immunocytochemistry at a dilution of 1:1000
following standard immunocytochemical techniques [136,137].
For caspase cleavage assays, embryo lysates were prepared and
reactions were carried out in duplicate using one embryo equivalent
oflysate(20 mL)and80 mL lysisbuffer.Reactions wereincubatedat
37uC for 1 hour with 5 mM of the caspase-3 fluorogenic substrate
Ac-DEVD-AMC (BioMol), after which 990 mL of water was added
and fluorescence was measured using a Hitachi F2000 Fluorescence
Spectrophotometer. Results were analyzed for statistical signifi-
cance using Student’s t-test of the means.
In situ hybridization and Alcian Blue Staining
Plasmids containing the Sox9 coding sequence, isolated by RT-PCR
from neural stage embryos (Fawcett & Klymkowsky, unpublished).
Digoxigenin-labeled antisense probes were generated against Sox9,
Slug [70], Sox2 [138], Sox3 [139], epidermal keratin [140], Xbra
[141], Antipodean (Apod) [142], and Xmenf [143] RNAs and in situ
hybridization was performed following standard protocols [22,72].
Alcian Blue staining was carried out as described previously [134].
Digital images were captured using a Nikon CoolPix 995 Camera
on an Inverted Leica M400 Photomicroskop. Images were
manipulated with Fireworks 8 software (Macromedia now Adobe)
using the ‘‘auto levels’’ and ‘‘curves’’ functions only.
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